START San Antonio

Clinical research site in San Antonio, Texas · 7400 MERTON MINTER ST, SAN ANTONIO, TX 78229-4404 · (615) 355-3451

As of July 2026, 49 paid clinical trials are recruiting at START San Antonio in San Antonio, Texas. Active studies at this site cover conditions such as Advanced Solid Tumor, Breast Cancer and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at START San Antonio (49)

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for Endometrial Cancer

50 locations incl. Phoenix

Sponsor: Genmab

Sex: Female·Age: 18+

Code: NCT07166094·Phase 3·Recruiting·Listed Sep 2025

Apply to this trial

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

for Neovascular Age-Related Macular Degeneration (NVAMD)

49 locations incl. Scottsdale

Sponsor: EyeBiotech Ltd.

Sex: All·Age: 18+

Code: NCT07205887·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for Kidney Disease

40 locations incl. Birmingham

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT06963827·Phase 3·Recruiting·Listed May 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

for Melanoma

31 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 16+

Code: NCT05355701·Phase 1·Recruiting·Listed May 2022

Apply to this trial

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for Breast Cancer

24 locations incl. Los Angeles

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT05768139·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

for Narcolepsy Type 1

29 locations incl. Auburn

Sponsor: Centessa Pharmaceuticals (UK) Limited

Sex: All·Age: 18 - 65

Code: NCT06752668·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for Pancreatic Ductal Adenocarcinoma (PDAC)

16 locations incl. Los Angeles

Sponsor: Verastem, Inc.

Sex: All·Age: 18+

Code: NCT07644559·Phase 2·Recruiting·Listed Jun 12, 2026

Apply to this trial

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

for Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma

11 locations incl. Birmingham

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07488676·Phase 1, Phase 2·Recruiting·Listed Mar 2026

Apply to this trial

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

for Endometrial Cancer

12 locations incl. Little Rock

Sponsor: Whitehawk Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07444814·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for Multiple Myeloma

10 locations incl. Scottsdale

Sponsor: C4 Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07284758·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

for Advanced or Metastatic Solid Tumors

15 locations incl. Santa Monica

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07205718·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

for Lung Cancer (Diagnosis)

11 locations incl. Palo Alto

Sponsor: bioAffinity Technologies Inc.

Sex: All·Age: 50 - 80

Code: NCT07168993·Recruiting·Listed Sep 2025

Apply to this trial

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

11 locations incl. Aurora

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT06384352·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

Study of CHS-114 in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

12 locations incl. Palo Alto

Sponsor: Coherus Oncology, Inc.

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05635643·Phase 1·Recruiting·Listed Dec 2022

Apply to this trial

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

for MTAP-deleted Solid Tumors

17 locations incl. Birmingham

Sponsor: Bayer

Sex: All·Age: 18+

Code: NCT06914128·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

for Small Cell Lung Cancer Metastatic or Locally Advanced

20 locations incl. Huntsville

Sponsor: SystImmune Inc.

Sex: All·Age: 18+

Code: NCT07080242·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Study of PYX-201 in Advanced Solid Tumors

for Solid Tumor

17 locations incl. Scottsdale

Sponsor: Pyxis Oncology, Inc

Sex: All·Age: 18+

Code: NCT05720117·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

for Ovarian Cancer

10 locations incl. Los Angeles

Sponsor: Nammi Therapeutics Inc

Sex: All·Age: 18+

Code: NCT06582017·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for Solid Tumor Malignancies

13 locations incl. Denver

Sponsor: Tasca Therapeutics

Sex: All·Age: 18+

Code: NCT07030257·Phase 1, Phase 2·Recruiting·Listed Jun 2025

Apply to this trial

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

for Ovarian Cancer

14 locations incl. Denver

Sponsor: OnCusp Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06234423·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.

for Solid Tumor

20 locations incl. Birmingham

Sponsor: Corbus Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT06603844·Phase 1, Phase 2·Recruiting·Listed Sep 2024

Apply to this trial

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

for HR+ HER2- Breast Cancer

7 locations incl. Los Angeles

Sponsor: Faeth Therapeutics

Sex: All·Age: 18+

Code: NCT07558733·Phase 1, Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

for Advanced/Metastatic Colorectal Adenocarcinoma

7 locations incl. Phoenix

Sponsor: Bayer

Sex: All·Age: 18+

Code: NCT07535112·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers

for Gastrointestinal Cancers

2 locations incl. Grand Rapids

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT07539311·Phase 2·Recruiting·Listed Apr 2026

Apply to this trial

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

for Breast Cancer

5 locations incl. Los Angeles

Sponsor: Regor Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT07524322·Phase 1·Recruiting·Listed Apr 2026

Apply to this trial

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

for Von Hippel-Lindau Disease

7 locations incl. Boston

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07405164·Phase 3·Recruiting·Listed Feb 2026

Apply to this trial

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

for Non-small Cell Lung Cancer (NSCLC)

9 locations incl. New Haven

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT07349537·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

for Advanced Breast Cancer

9 locations incl. Duarte

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07318805·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Study in Advanced Solid Tumor Patients

for Advanced Solid Tumor

5 locations incl. Boston

Sponsor: Callio Therapeutics

Sex: All·Age: 18+

Code: NCT07300943·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

8 locations incl. Palo Alto

Sponsor: FoRx Therapeutics AG

Sex: All·Age: 18+

Code: NCT07356453·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability

for Smoking Behaviors

2 locations incl. Knoxville

Sponsor: JT International SA

Sex: All·Age: 22 - 65·Accepts healthy volunteers

Code: NCT07476144·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

for Renal Cell Carcinoma

5 locations incl. Boston

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07195682·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

for Solid Tumours

9 locations incl. Irvine

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07160725·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

DPTX3186 in Wnt Pathway Activated Solid Tumors

for Solid Tumors

2 locations incl. San Antonio

Sponsor: Dewpoint Therapeutics

Sex: All·Age: 18+

Code: NCT07312903·Phase 1·Recruiting·Listed Dec 2025

Apply to this trial

Study of GS-5319 in Adults With Solid Tumors

for Advanced Solid Tumor

3 locations incl. Boston

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT07128303·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Study of ZW251 in Participants With Advanced Solid Tumors

for Hepatocellular Carcinoma

8 locations incl. San Francisco

Sponsor: Zymeworks BC Inc.

Sex: All·Age: 18+

Code: NCT07164313·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

for Head and Neck Squamous Cell Carcinoma HNSCC

6 locations incl. Denver

Sponsor: Sutro Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT07227168·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

for Advanced Solid Tumor

5 locations incl. Rogers

Sponsor: Adcendo ApS

Sex: All·Age: 18+

Code: NCT06597721·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for Platinum-resistant Ovarian Cancer

7 locations incl. Los Angeles

Sponsor: MacroGenics

Sex: Female·Age: 18+

Code: NCT06730347·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

7 locations incl. Scottsdale

Sponsor: Tagworks Pharmaceuticals BV

Sex: All·Age: 18+

Code: NCT06959706·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Showing the 40 most relevant of 49 recruiting trials at this site. Browse all with filters →

More research sites in San Antonio

University of Texas Health Science Center at San Antonio (85 trials)
NEXT Oncology (56 trials)
Children's Hospital of San Antonio (32 trials)
Methodist Children's Hospital of South Texas (24 trials)
The University of Texas Health Science Center at San Antonio (21 trials)
UT Health San Antonio (16 trials)
GSK Investigational Site (13 trials)
Texas Dermatology and Laser Specialists (13 trials)
Texas Oncology - San Antonio (12 trials)
Brooke Army Medical Center (11 trials)

Explore more

Paid clinical trials in San Antonio, TX · Texas clinical trials